Axcella Health (NASDAQ:AXLA – Get Rating) and Adaptimmune Therapeutics (NASDAQ:ADAP – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Institutional & Insider Ownership 71.1% of Axcella Health shares […]
Axcella Health Inc. (NASDAQ:AXLA – Get Rating) – Research analysts at HC Wainwright issued their FY2027 EPS estimates for Axcella Health in a note issued to investors on Monday, April 3rd. HC Wainwright analyst E. Arce anticipates that the company will earn ($1.38) per share for the year. HC Wainwright has a “Neutral” rating on […]
Phase 2b/3 study may proceed under U.S. Investigational New Drug applicationStudy design now accepted by U.S. and U.K. regulatory authoritiesAxcella to present at Long COVID forum co-sponsored by BIO and Solve M.E.Axcella to host a conference call February 16 at 8:00 a.m. ET; To register, click hereCAMBRIDGE, Mass.-.
Axcella Therapeutics (AXLA) Announces FDA IND Clearance Supporting Regulatory Path to Registration of AXA1125 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.